A case study using the Agilent 6470B for the trace-level quantification of mutagenic nitrosamine impurities
Identification and quantification of trace azido, NDSRI, and nitrosamine impurities in drug substances and products is under increased regulatory scrutiny. LC/MS-based analytical strategies can be easily adopted. Risky preparations must be tested for nitrosamine contamination via validated and appropriately sensitive analytical methods.
Highlights of LC/MS/MS approaches
Learn all about nitrosamine analysis solutions by Agilent from the below on-demand webinars:
Complete workflows, proven methods and tips for nitrosamine detection and quantification in several drug compound
Confidently detect nitrosamine impurities in a broad spectrum of pharmaceuticals, an easy-to-use guide to complete workflows for 10 drug compounds
Trace nitrosamine detection and quantification requires advanced and sensitive tools. Find complete workflows and tips to aid your success.
Learn current regulatory guidelines and GC/MS- and LC/MS-based analytical strategies to detect and quantify nitrosamines in APIs and drug products.
Learn more about Nitrosamine Analysis by Agilent
Please complete and submit the form below to access the LC/MS resources contained on this page.
If you would like a quote or to connect with an Agilent representative, please complete the relevant sections.